202:
79:
160:
143:
120:
32:
220:
216:
61:
Hello all. A short newsletter reflecting a quiet month in recognized content. If there's other types of content you'd like to see in the newsletter feel free to post suggestions
207:
62:
21:
176:
17:
159:
82:
172:
168:
146:
163:
215:
You are receiving this because you added your name to the WikiProject
Medicine
175:
for identified issues, or comment on whether it meets the FA criteria at
123:
129:
31:
152:
94:
135:
88:
30:
219:. If you no longer wish to receive the newsletter, please
206:Newsletter ideas, comments, and criticisms welcome
196:No news, which may be good news. Happy editing.
65:. Otherwise, here's your update for the month:
8:
142:
119:
108:
67:
7:
201:
78:
18:Knowledge (XXG):WikiProject Medicine
28:
200:
158:
141:
118:
77:
53:WikiProject Medicine Newsletter
1:
239:
70:Newly recognized content
169:featured article review
40:Issue 20—December 2022
35:
34:
111:Nominated for review
83:Stanley J. Korsmeyer
113:
72:
190:
133:, under review by
109:
68:
36:
224:
188:
185:
184:
180:
167:is nominated for
156:
139:
107:
106:
98:
230:
221:remove your name
214:
204:
203:
166:
162:
155:
149:
145:
144:
138:
132:
126:
122:
121:
114:
97:
91:
85:
81:
80:
73:
56:
55:
54:
41:
238:
237:
233:
232:
231:
229:
228:
227:
226:
191:
151:
134:
128:
93:
87:
52:
51:
50:
39:
26:
25:
24:
12:
11:
5:
236:
234:
198:
197:
192:
187:
183:
182:
157:
140:
105:
104:
102:
101:
100:
99:
92:, reviewed by
59:
58:
45:
43:
42:
29:
27:
15:
14:
13:
10:
9:
6:
4:
3:
2:
235:
225:
222:
218:
212:
211:
209:
195:
194:
193:
181:
178:
174:
170:
165:
161:
154:
148:
147:Lucien Brouha
137:
131:
125:
116:
115:
112:
103:
96:
90:
84:
75:
74:
71:
66:
64:
57:
48:
47:
46:
38:
37:
33:
23:
19:
217:mailing list
213:
205:
199:
186:
177:its FAR page
117:
110:
76:
69:
60:
49:
44:
189:WP:MED News
164:Lung cancer
130:David notMD
171:. See its
22:Newsletter
173:talk page
153:Schwede66
95:Schwede66
136:Mertbiol
124:Thiamine
89:Ajpolino
20: |
150:nom.
127:nom.
86:nom.
16:<
208:here
63:here
223:.
210:.
179:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
